Loading organizations...
Loading organizations...
Comprehensive biopharmaceutical custom development and production services.
CMAB BioPharm has raised $72.0M across 2 funding rounds.
CMAB BioPharm has raised $72.0M in total across 2 funding rounds.
CMAB BioPharm has raised $72.0M in total across 2 funding rounds.
CMAB BioPharm's investors include C-Bridge Capital, Cormorant Asset Management, Tigermed, BioBAY, Mengjiao Jiang, I-Bridge Capital.
CMAB BioPharm has raised $72.0M across 2 funding rounds. Most recently, it raised $34.0M Series B in April 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 2, 2018 | $34.0M Series B | C-Bridge Capital, Cormorant Asset Management, Tigermed | |
| Jan 2, 2018 | $38.0M Series A | BioBAY, Mengjiao Jiang | I-Bridge Capital |